National Medical Products Administration, Provisions for the Oversight of the Production of Export Pharmaceuticals (Draft for Comments)

国家药品监督管理局出口药品生产监督管理规定 (征求意见稿)

August 26, 2024 | BY

Susan Mok

Export pharmaceuticals commissioned for production from a foreign pharmaceutical manufacturer may not be sold and used in the PRC

Issued: August 1, 2024

 

This premium content is reserved for
China Law & Practice Subscribers.

  • A database of over 3,000 essential documents including key PRC legislation translated into English
  • A choice of newsletters to alert you to changes affecting your business including sector specific updates
  • Premium access to the mobile optimized site for timely analysis that guides you through China's ever-changing business environment
For enterprise-wide or corporate enquiries, please contact our experienced Sales Professionals at +44 (0)203 868 7546 or [email protected]